Latest Whitepapers

Whitepaper
Master Seamless CE-SDS Method Transfer
This whitepaper presents validated bridging protocols and real-world case studies demonstrating successful method transfer strategies.

Whitepaper
Optimizing Cell-Free DNA Workflows in Liquid Biopsy
This whitepaper explores comprehensive strategies for overcoming workflow limitations while maximizing sensitivity in next-generation sequencing (NGS) applications.

Whitepaper
Streamlining Single-Cell Analysis With Automated Tissue Dissociation
This whitepaper highlights studies showcasing how optimized dissociation technologies enhance workflows in oncology, immunology, neuroscience and beyond.

Whitepaper
Reveal Spatial Biomarkers With Multiplexed Imaging Mass Cytometry
This whitepaper explores the translational and clinical applications of IMC to develop biomarkers and future treatment strategies in neuro-oncology and neurodegenerative studies.

Whitepaper
Unlock Powerful Proteomic Data Analysis
This whitepaper explores how automated data management and integrated tools can revolutionize proteomics by simplifying workflows and enhancing data accessibility.

Whitepaper
Identifying Protein Biomarkers for Aging Research
This whitepaper explores innovative proteomic tools that offer insights into protein signatures and that can serve as biomarkers for aging.

Whitepaper
The Economics of Synthetic mRNA Capping Strategies
This whitepaper evaluates the results of a study into the three main capping options available to manufacturers, highlighting expert insights on mRNA capping costs and customer needs.

Whitepaper
Mass Spectrometry-Based Solutions for Drugging the Undruggable
This whitepaper highlights new drug discovery platforms that can uncover and pharmacologically target previously undruggable proteins targets, making them accessible to therapeutic intervention by small-molecule drugs.

Whitepaper
Multiomic Sequencing Solutions To Revolutionize Human Disease Research
Understanding the mechanisms of human disease requires a multiomic approach; however, legacy multiomic methods require multiple platforms and complex processes with lengthy turnaround times and considerable costs.

Whitepaper
How To Accelerate Vaccine Production – And Avoid Speed Bumps
This article explores key challenges in vaccine development scale up and highlights various strategies for overcoming them.
Advertisement